More on Bupropion for Smoking Cessation
In a recent study, a 7-week course of sustained-release bupropion doubled the rate of abstinence from smoking at 1 year -- 23 percent with bupropion vs. 12 percent with placebo ( JW Nov 15 1997, p. 173, accession number 971031001, and N Engl J Med 1997; 337:1195). In 2 new reports, researchers sponsored by the maker of sustained-release bupropion add …
We believe this patient is probably the first case of gradual ::: onset dyskinesia with mirtazapine treatment. Mirtazapine has ::: been suggested for treating antipsychotic-induced akathisia. ::: [5] Earlier reports [2],[4] and also our patient suggest that ::: one should be observant while treating patients with ::: mirtazapine for the development of dyskinesia or worsening of ::: akathisia. We agree with Kumar et al. [6] that one should be ::: aware that antidepressant medications can cause various ::: movement disorders.